FIBROBIOLOGICS INC (FBLG)

US31573L1052 - Common Stock

1.985  -0.01 (-0.75%)

After market: 1.99 +0 (+0.25%)

FIBROBIOLOGICS INC

NASDAQ:FBLG (1/2/2025, 8:00:02 PM)

After market: 1.99 +0 (+0.25%)

1.985

-0.01 (-0.75%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%78.69%
Sales Q2Q%N/A
CRS0
6 Month-59.74%
Overview
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Ins Owners17.59%
Inst Owners9.63%
Market Cap68.80M
Shares34.66M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts82.22
Short Float %9.43%
Short Ratio15.63
IPO01-31 2024-01-31
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

FBLG Daily chart

Company Profile

FibroBiologics, Inc. engages in the development and commercialization of cell therapies. The company is headquartered in Houston, Texas and currently employs 10 full-time employees. The company went IPO on 2024-01-31. The firm operates as a biopharmaceutical company. The company is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. The company also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.

Company Info

FIBROBIOLOGICS INC

455 E. Medical Center Blvd, Suite 300

Houston TEXAS

P: 12816715150

Employees: 10

Website: https://fibrobiologics.com/

FBLG News

News Image3 days ago - Fibrobiologics, Inc.FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing
News Image3 days ago - Fibrobiologics, Inc.FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

HOUSTON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (

News Image3 days ago - D. Boral CapitalD. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing
News Image11 days ago - Fibrobiologics, Inc.FibroBiologics Announces $25 Million Financing
News Image11 days ago - Fibrobiologics, Inc.FibroBiologics Announces $25 Million Financing

HOUSTON, Dec. 23, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (

News Imagea month ago - Fibrobiologics, Inc.FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

FBLG Twits

Here you can normally see the latest stock twits on FBLG, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example